Part B Insider - 2013 Issue 12
ICD-10: Consolidate Esophageal Cancer Codes
Subscribe or sign in to view the full article.
Article Overview
This article explains how esophageal cancer coding changes from ICD-9 to ICD-10, with emphasis on the overall structure of the diagnosis code set and the shift from more granular ICD-9 terms to a smaller ICD-10 set. It also notes the related carcinoma in situ crosswalk and is aimed at coding professionals tracking diagnosis code changes for implementation planning and code lookup reference.
Why This Topic Matters
Understanding the ICD-9 to ICD-10 transition for esophageal neoplasms helps coders, billers, and compliance teams prepare for diagnosis code lookup changes and recognize which parts of the topic retain a direct crosswalk versus a consolidated structure.
Article Sections
-
Curb Redundancies
This section discusses the overall change in the malignant esophageal neoplasm code structure between ICD-9 and ICD-10. It highlights the broader shift in terminology and grouping within the diagnosis code set.
-
Match Carcinoma in situ Codes
This section addresses the carcinoma in situ portion of the esophageal neoplasm topic. It notes the corresponding ICD-9 and ICD-10 diagnosis code comparison and the timing of the transition.
What You Will Learn
- How the esophageal cancer diagnosis code set changes between ICD-9 and ICD-10
- Which portions of the topic are discussed as direct crosswalks
- How the article frames the relationship between malignant neoplasm coding and carcinoma in situ coding
- What implementation timing is referenced for the ICD-10 transition
Who Should Read This
- Medical coders
- Coding educators
- Billing staff
- Compliance professionals
- Revenue cycle teams
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com